The crystal structure of 1-propyl-2-nitro-imidazole oxide, C6H9N3O3
Open Access
- 20 July 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 238 (5) , 917-918
Abstract
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.8810(10)∘, V = 807.74(6) Å3, Z = 4, R gt (F) = 0.0455, wR ref (F 2) = 0.1166, T = 170.0 K.Keywords
Funding Information
- Shanxi Province Higher Education Science and Technology Innovation (2022L619)
This publication has 8 references indexed in Scilit:
- The crystal structure of 1-ethyl-2-nitro-imidazole oxide, C5H7N3O3Zeitschrift für Kristallographie - New Crystal Structures, 2023
- Crystal structure refinement withSHELXLActa Crystallographica Section C Structural Chemistry, 2015
- Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping SicknessPLOS Neglected Tropical Diseases, 2010
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- 5-Nitroimidazole Drugs Effective against Metronidazole-Resistant Trichomonas vaginalis and Giardia duodenalisAntimicrobial Agents and Chemotherapy, 2006
- Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 2000
- Nitroimidazoles and imaging hypoxiaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995